AKBA - Akebia GAAP EPS of -$0.08 beats by $0.01 revenue of $42.05M misses by $6.13M
2023-11-08 07:33:40 ET
More on Akebia
- Akebia Therapeutics: Waiting For Round 2
- Akebia Therapeutics, Inc. (AKBA) Q2 2023 Earnings Call Transcript
- Akebia Q3 2023 Earnings Preview
- Akebia kidney disease therapy undergoes FDA review again
- Seeking Alpha’s Quant Rating on Akebia
For further details see:
Akebia GAAP EPS of -$0.08 beats by $0.01, revenue of $42.05M misses by $6.13M